NCT01634191View on ClinicalTrials.gov

Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

March 1, 2012

Study Completion Date

April 1, 2012

Conditions

Healthy Volunteer

Interventions

DRUG

Apremilast

One oral 30 mg dose of apremilast

Trial Locations (2)

66219

PRA International, Lenexa

75247

Clinical Development Services, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY